Performance was driven by strong momentum across the tobacco businesses, says CEO. Read More
The company says its business performed well against difficult year-to-year comparisons. Read More
In local currencies, sales increased by 10 percent for the third quarter. Read More
The firm is encouraged by the FDA decision to reconsider its PMTA for vapor products. Read More
Performance was driven by sales of IQOS and share gains for combustible products.Read More
The company is also exploring the potential for reduced-risk products in Egypt. Read More
The company has made progress through targeted investments and market trails. Read More
Some shareholders opposed resolutions dealing with directors’ remuneration.Read More
The company continued the rollout of its flagship product in the third quarter. Read More
The move will help the company comply with New York Stock Exchange requirements. Read More
Recent Posts
- U.S. Market Poised for Disruption
- New KT&G CEO Engages Employees
- Sullivan and Mish Resign From 22nd Century Board
- Philip Morris Pakistan Urges Action Against Illicit Trade
- Philippines: Momentum Building for Disposables Ban
- Healthcare Providers Urged to Discuss Vapes
- Vape Shops Challenge Kentucky Registry Bill
- Smokers Ordered to Keep Their Distance
- Former BAT Company Does Ruble-Yuan Swaps
- Cuban Origin Ruling Final: Court
- Mustafa Named Influential Executive
- CTP Launches Webpage on Relative Risks
- PCA Reflects on Successful Trade Show
- Britain’s Generation Ban Passes First Vote
- PMI Eyes Philippines Leaf for Smoke-Free